Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Nov;7(11):5431-5438.
doi: 10.1002/cam4.1790. Epub 2018 Oct 10.

Modification of American Joint Committee on cancer prognostic groups for renal cell carcinoma

Ning Shao  1   2 , Hong-Kai Wang  1   2 , Yao Zhu  1   2 , Ding-Wei Ye  1   2
Affiliations

Modification of American Joint Committee on cancer prognostic groups for renal cell carcinoma

Ning Shao et al. Cancer Med. 2018 Nov.

Abstract

Background: To compare the predictive value of the current AJCC stage grouping for renal cell carcinoma (RCC) to our modifications.

Patients and methods: A total of 2120 patients with RCC from Fudan University Shanghai Cancer Center (FUSCC) database and 74 506 counterparts from SEER database were included. Cox regression was used to calculate the relative impacts between prognostic groups. The predictive accuracy of overall survival (OS) was assessed using the concordance index (C-index), which was compared by likelihood ratio test.

Results: In FUSCC cohort, the 5-year-OS rate for T3N0M0 patients was higher than T1-3N1M0 (72.7% vs 38.1%). The 5-year-OS rate for T4N0M0 was 36.2%, which was close to T1-3N1M0 but not to T4N1M0 (0%) and TanyNanyM1 (12.6%). The elements of AJCC groups were regrouped according to the ranks of hazard ratios. The modified stages II (T3N0M0), III (T1-3N1M0, T4N0M0), and IV (T4N1M0, TanyNanyM1) exhibited greater survival stratification than AJCC groups. The modifications were validated in SEER cohort and yielded similar survival outcomes. The predictive accuracy of OS in modified prognostic groups was significantly higher than AJCC groups in stages II-IV subgroups in both FUSCC (C-index: 0.801 vs 0.779, P < 0.001) and SEER cohort (C-index: 0.770 vs 0.764, P < 0.001).

Conclusions: The modified AJCC prognostic groups for RCC provided significantly improved survival prediction compared with the 8th AJCC edition. A precise risk stratification of modified stages II-IV disease provides an important basis for risk-equivalent treatment recommendation.

Keywords: AJCC staging system; overall survival; renal cell carcinoma.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Kaplan‐Meier survival curves of the patients in T1‐3N1M0, T1N0M0, T2N0M0, T3N0M0, T4N0M0, T4N1M0, and TanyNanyM1 from (A) the FUSCC cohort and (B) the SEER cohort. Color variation on the Y axis of the heatmaps reflected the 5‐year‐OS rates variation of these patients from (C) the FUSCC cohort and (D) the SEER cohort
Figure 2
Figure 2
(A) Kaplan‐Meier survival curves for the patients of different TNM subgroup from the SEER cohort. (B) The 8th Editions of the AJCC Staging Definitions and the Modified 8th Staging Definitions for RCC
Figure 3
Figure 3
Kaplan‐Meier survival curves of the patients from (A) the FUSCC cohort and (B) the SEER cohort according to the 8th AJCC staging system. Kaplan‐Meier survival curves for the patients from (C) the FUSCC cohort and (D) the SEER cohort according to the modified 8th staging system
See this image and copyright information in PMC

Comment in

References

    1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017:67:7‐30. - PubMed
    1. Larkin J, Paine A, Tumur I, et al. Second‐line treatments for the management of advanced renal cell carcinoma: systematic review and meta‐analysis. Expert Opin Pharmacother. 2013;14:27‐39. - PubMed
    1. Moch H, Artibani W, Delahunt B, et al. Reassessing the current UICC/AJCC TNM staging for renal cell carcinoma. Eur Urol. 2009;56:636‐643. - PubMed
    1. Howard GE, Wood CG. Staging refinements in renal cell carcinoma. Curr Opin Urol. 2006;16:317‐320. - PubMed
    1. Li ZS, Yao K, Chen P, et al. Modification of N staging systems for penile cancer: a more precise prediction of prognosis. Br J Cancer. 2015;112:1766‐1771. - PMC - PubMed

Publication types